202 related articles for article (PubMed ID: 15192787)
21. Cholangiocarcinoma.
Blechacz BR; Gores GJ
Clin Liver Dis; 2008 Feb; 12(1):131-50, ix. PubMed ID: 18242501
[TBL] [Abstract][Full Text] [Related]
22. Surgical management of cholangiocarcinoma.
Jarnagin WR; Shoup M
Semin Liver Dis; 2004 May; 24(2):189-99. PubMed ID: 15192791
[TBL] [Abstract][Full Text] [Related]
23. KL-6 mucin is a useful immunohistochemical marker for cholangiocarcinoma.
Tang W; Guo Q; Qu X; Inagaki Y; Seyama Y; Midorikawa Y; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
Oncol Rep; 2007 Apr; 17(4):737-41. PubMed ID: 17342308
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
[TBL] [Abstract][Full Text] [Related]
25. A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma.
Bamrungphon W; Prempracha N; Bunchu N; Rangdaeng S; Sandhu T; Srisukho S; Boonla C; Wongkham S
Cancer Lett; 2007 Mar; 247(2):301-8. PubMed ID: 16793202
[TBL] [Abstract][Full Text] [Related]
26. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.
Uenishi T; Yamazaki O; Tanaka H; Takemura S; Yamamoto T; Tanaka S; Nishiguchi S; Kubo S
Ann Surg Oncol; 2008 Feb; 15(2):583-9. PubMed ID: 17955299
[TBL] [Abstract][Full Text] [Related]
27. [Diagnostics and treatment of cholangiocarcinoma].
Mantel HT; Verdonk RC; van Dullemen HM; Gietema JA; Slooff MJ; Porte RJ
Ned Tijdschr Geneeskd; 2008 May; 152(18):1037-41. PubMed ID: 18547024
[TBL] [Abstract][Full Text] [Related]
28. Magnetic resonance imaging of cholangiocarcinoma.
Manfredi R; Barbaro B; Masselli G; Vecchioli A; Marano P
Semin Liver Dis; 2004 May; 24(2):155-64. PubMed ID: 15192788
[TBL] [Abstract][Full Text] [Related]
29. Small pancreatic carcinoma misdiagnosed as superficially spreading cholangiocarcinoma.
Igami T; Yokoyama Y; Nishio H; Ebata T; Shimoyama Y; Nakamura S; Nagino M
J Hepatobiliary Pancreat Surg; 2009; 16(4):579-84. PubMed ID: 19259611
[TBL] [Abstract][Full Text] [Related]
30. Heat shock proteins 27 and 70 are potential biliary markers for the detection of cholangiocarcinoma.
Sato Y; Harada K; Sasaki M; Yasaka T; Nakanuma Y
Am J Pathol; 2012 Jan; 180(1):123-30. PubMed ID: 22051775
[TBL] [Abstract][Full Text] [Related]
31. Recurrence of intrahepatic cholangiocarcinoma nine years after surgical resection.
Kitagawa D; Taketomi A; Aishima S; Kuroda Y; Gion T; Shirabe K; Shimada M; Maehara Y
Hepatogastroenterology; 2008; 55(84):1085-8. PubMed ID: 18705334
[TBL] [Abstract][Full Text] [Related]
32. Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma.
Liu XF; Kong FM; Xu Z; Yu SP; Sun FB; Zhang CS; Huang QX; Zhou XT; Song ZW
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):407-11. PubMed ID: 17690039
[TBL] [Abstract][Full Text] [Related]
33. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
[TBL] [Abstract][Full Text] [Related]
34. Biliary brushing cytology.
Selvaggi SM
Cytopathology; 2004 Apr; 15(2):74-9. PubMed ID: 15056166
[TBL] [Abstract][Full Text] [Related]
35. Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning.
Masselli G; Gualdi G
Abdom Imaging; 2008; 33(4):444-51. PubMed ID: 17638040
[TBL] [Abstract][Full Text] [Related]
36. What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma?
Slattery JM; Sahani DV
Oncologist; 2006 Sep; 11(8):913-22. PubMed ID: 16951395
[TBL] [Abstract][Full Text] [Related]
37. Serum levels of variants of transthyretin down-regulation in cholangiocarcinoma.
Liu L; Wang J; Liu B; Dai S; Wang X; Chen J; Huang L; Xiao X; He D
J Cell Biochem; 2008 Jun; 104(3):745-55. PubMed ID: 18275060
[TBL] [Abstract][Full Text] [Related]
38. Education and imaging. Hepatobiliary and pancreatic: cholangiocarcinoma in a double bile duct.
Yamamoto T; Nakahira A; Kubo S; Uenishi T; Ichikawa T; Hai S; Tanaka S; Hirohashi K
J Gastroenterol Hepatol; 2006 Dec; 21(12):1859. PubMed ID: 17074028
[No Abstract] [Full Text] [Related]
39. Review article: the modern diagnosis and therapy of cholangiocarcinoma.
Malhi H; Gores GJ
Aliment Pharmacol Ther; 2006 May; 23(9):1287-96. PubMed ID: 16629933
[TBL] [Abstract][Full Text] [Related]
40. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR
Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
